Read + Share
Amedeo Smart
Independent Medical Education
Pourhassan H, Yang D, Afkhami M, Pillai R, et al. High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemia. Am J Hematol 2022 Feb 7. doi: 10.1002/ajh.26490.PMID: 35132678
Email
LinkedIn
Facebook
Twitter
Privacy Policy